Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s)

Vascular Pharmacology

Volumn 42, Issue 3, 2005, Pages 109-118

  Batenburg, Wendy W ^a   Tom, Beril ^a   Schuijt, Martin P ^a   Danser, A H Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin; Bradykinin; Endothelium derived hyperpolarizing factor; Gender; Nitrosothiol; NO; Receptor

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ARACHIDONIC ACID; BRADYKININ; BRADYKININ B2 RECEPTOR; CANDESARTAN; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HYDROGEN PEROXIDE; INDOMETACIN; IRBESARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM ION; S NITROSOTHIOL;

AGE DISTRIBUTION; CELL CULTURE; CELL FUNCTION; DIMERIZATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART LEFT VENTRICLE MASS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 15744370696     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.01.005     Document Type: Review

References (81)

1. 1 receptor antagonist J. Biol. Chem. 276 2001 39721 39726
2. S.L. Archer, F.S. Gragasin, X. Wu, S. Wang, S. McMurtry, D.H. Kim, M. Platonov, A. Koshal, K. Hashimoto, W.B. Campbell, J.R. Falck, and E.D. Michelakis Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels Circulation 107 2003 769 776
3. W.W. Batenburg, I.M. Garrelds, C.C. Bernasconi, L. Juillerat-Jeanneret, J.P. van Kats, P.R. Saxena, and A.H.J. Danser Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries Circulation 109 2004 2296 2301
4. W.W. Batenburg, I.M. Garrelds, J.P. van Kats, P.R. Saxena, and A.H.J. Danser Mediators of bradykinin-induced vasorelaxation in human coronary microarteries Hypertension 43 2004 488 492
5. W.W. Batenburg, R. Popp, I. Fleming, R. de Vries, I.M. Garrelds, P.R. Saxena, and A.H.J. Danser Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br. J. Pharmacol. 142 2004 125 135
6. W.W. Batenburg, R. de Vries, P.R. Saxena, and A.H.J. Danser l-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J. Hypertens. 22 2004 1927 1936
7. S. Bergaya, R.H. Hilgers, P. Meneton, Y. Dong, M. Bloch-Faure, T. Inagami, F. Alhenc-Gelas, B.I. Levy, and C.M. Boulanger Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors Circ. Res. 94 2004 1623 1629
8. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, and R.A. Cohen Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368 1994 850 853
9. M. Brink, P. Erne, M. de Gasparo, H. Rogg, A. Schmid, P. Stulz, and G. Bullock Localization of the angiotensin II receptor subtypes in the human atrium J. Mol. Cell. Cardiol. 28 1996 1789 1799
10. R. Busse, G. Edwards, M. Feletou, I. Fleming, P.M. Vanhoutte, and A.H. Weston EDHF: bringing the concepts together Trends Pharmacol. Sci. 23 2002 374 380
11. R. Bychkov, M.P. Burnham, G.R. Richards, G. Edwards, A.H. Weston, M. Feletou, and P.M. Vanhoutte Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF Br. J. Pharmacol. 137 2002 1346 1354
12. W.B. Campbell, D. Gebremedhin, P.F. Pratt, and D.R. Harder Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ. Res. 78 1996 415 423
13. R.M. Carey, Z.Q. Wang, and H.M. Siragy Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function Hypertension 35 2000 155 163
14. A.H.J. Danser, R. de Vries, R.G. Schoemaker, and P.R. Saxena Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors J. Hypertens. 16 1998 239 244
15. A.H.J. Danser, F.H.M. Derkx, M.A.D.H. Schalekamp, H.W. Hense, G.A.J. Riegger, and H. Schunkert Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans J. Hypertens. 16 1998 853 862
16. A.H.J. Danser, B. Tom, R. de Vries, and P.R. Saxena l-NAME resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition Br. J. Pharmacol. 131 2000 195 202
17. R.L. Davisson, M.D. Travis, J.N. Bates, and S.J. Lewis Hemodynamic effects of l- and d-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites Circ. Res. 79 1996 256 262
18. J. Deinum, J.M. van Gool, M.J. Kofflard, F.J. ten Cate, and A.H.J. Danser Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy Hypertension 38 2001 1278 1281
19. Ca) channels Hypertension 37 2001 301 307
20. G. Edwards, K.A. Dora, M.J. Gardener, C.J. Garland, and A.H. Weston K+ is an endothelium-derived hyperpolarizing factor in rat arteries Nature 396 1998 269 272
21. G. Edwards, M. Feletou, M.J. Gardener, C.D. Glen, G.R. Richards, P.M. Vanhoutte, and A.H. Weston Further investigations into the endothelium-dependent hyperpolarizing effects of bradykinin and substance P in porcine coronary artery Br. J. Pharmacol. 133 2001 1145 1153
22. Y. Endo, S. Arima, H. Yaoita, K. Tsunoda, K. Omata, and S. Ito Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats J. Vasc. Res. 35 1998 421 427
23. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
24. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism Hypertension 31 1998 349 355
25. E.F. Grady, L.A. Sechi, C.A. Griffin, M. Schambelan, and J.E. Kalinyak Expression of AT2 receptors in the developing rat fetus J. Clin. Invest. 88 1991 921 933
26. H.J. Grone, M. Simon, and E. Fuchs Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney Am. J. Physiol. 262 1992 F326 F331
27. R.E. Hannan, E.A. Davis, and R.E. Widdop Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide Br. J. Pharmacol. 140 2003 987 995
28. L. Hein, G.S. Barsh, R.E. Pratt, V.J. Dzau, and B.K. Kobilka Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice Nature 377 1995 744 747
29. J.J. Hwa, L. Ghibaudi, P. Williams, and M. Chatterjee Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed Am. J. Physiol. 266 1994 H952 H958
30. T. Ichiki, P.A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B.L. Hogan, and T. Inagami Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor Nature 377 1995 748 750
31. X.Q. Jin, N. Fukuda, J.Z. Su, Y.M. Lai, R. Suzuki, Y. Tahira, H. Takagi, Y. Ikeda, K. Kanmatsuse, and H. Miyazaki Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells Hypertension 39 2002 1021 1027
32. J. Katada, and M. Majima AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions Br. J. Pharmacol. 136 2002 484 491
33. B.K. Kemp, and T.M. Cocks Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries Br. J. Pharmacol. 120 1997 757 762
34. S. Kurisu, R. Ozono, T. Oshima, M. Kambe, T. Ishida, H. Sugino, H. Matsuura, K. Chayama, Y. Teranishi, O. Iba, K. Amano, and H. Matsubara Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis Hypertension 41 2003 99 107
35. R.J. Lang, J.R. Harvey, and E.L. Mulholland Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-l-cysteine activation of Ca2+-activated K+ (BK(Ca)) channels in myocytes of the guinea-pig taenia caeca Br. J. Pharmacol. 139 2003 1153 1163
36. D.Y. Li, Y.C. Zhang, M.I. Philips, T. Sawamura, and J.L. Mehta Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation Circ. Res. 84 1999 1043 1049
37. Y.H. Liu, X.P. Yang, V.G. Sharov, O. Nass, H.N. Sabbah, E. Peterson, and O.A. Carretero Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors J. Clin. Invest. 99 1997 1926 1935
38. M.Y. Liu, Y. Hattori, A. Sato, R. Ichikawa, X.H. Zhang, and I. Sakuma Ovariectomy attenuates hyperpolarization and relaxation mediated by endothelium-derived hyperpolarizing factor in female rat mesenteric artery: a concomitant decrease in connexin-43 expression J. Cardiovasc. Pharmacol. 40 2002 938 948
39. F. Lovren, and C.R. Triggle Involvement of nitrosothiols, nitric oxide and voltage-gated K+ channels in photorelaxation of vascular smooth muscle Eur. J. Pharmacol. 347 1998 215 221
40. A. MaassenVanDenBrink, R. de Vries, P.R. Saxena, M.A.D.H. Schalekamp, and A.H.J. Danser Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase Cardiovasc. Res. 44 1999 407 415
41. T. Matoba, H. Shimokawa, K. Morikawa, H. Kubota, I. Kunihiro, L. Urakami-Harasawa, Y. Mukai, Y. Hirakawa, T. Akaike, and A. Takeshita Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels Arterioscler. Thromb. Vasc. Biol. 23 2003 1224 1230
42. T. Matsumoto, R. Ozono, T. Oshima, H. Matsuura, T. Sueda, G. Kajiyama, and M. Kambe Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure Cardiovasc. Res. 46 2000 73 81
43. I.L. Megson, S.A. Holmes, K.S. Magid, R.J. Pritchard, and F.W. Flitney Selective modifiers of glutathione biosynthesis and 'repriming' of vascular smooth muscle photorelaxation Br. J. Pharmacol. 130 2000 1575 1580
44. J.V. Mombouli, and P.M. Vanhoutte Endothelium-derived hyperpolarizing factor(s): updating the unknown Trends Pharmacol. Sci. 18 1997 252 256
45. D.H. Munzenmaier, and A.S. Greene Opposing actions of angiotensin II on microvascular growth and arterial blood pressure Hypertension 27 1996 760 765
46. S. Nouet, and C. Nahmias Signal transduction from the angiotensin II AT2 receptor Trends Endocrinol. Metab. 11 2000 1 6
47. S. Phoon, and L.G. Howes Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)-receptors J. Renin-Angiotensin-Aldosterone Syst. 3 2002 36 39
48. O. Rafikova, R. Rafikov, and E. Nudler Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control Proc. Natl. Acad. Sci. U. S. A. 99 2002 5913 5918
49. V. Regitz-Zagrosek, M. Neuss, C. Warnecke, J. Holzmeister, A.G. Hildebrandt, and E. Fleck Subtype 2 and atypical angiotensin receptors in the human heart Basic Res. Cardiol. 91 1996 73 77
50. I. Sakuma, M.Y. Liu, A. Sato, T. Hayashi, A. Iguchi, A. Kitabatake, and Y. Hattori Endothelium-dependent hyperpolarization and relaxation in mesenteric arteries of middle-aged rats: influence of oestrogen Br. J. Pharmacol. 135 2002 48 54
51. J.J. Saris, M.A. van Dijk, I. Kroon, M.A.D.H. Schalekamp, and A.H.J. Danser Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm Hypertension 35 2000 764 768
52. R.E. Schmieder, J. Erdmann, C. Delles, J. Jacobi, E. Fleck, K. Hilgers, and V. Regitz-Zagrosek Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans J. Am. Coll. Cardiol. 37 2001 175 182
53. M.P. Schuijt, R. de Vries, P.R. Saxena, and A.H.J. Danser No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats J. Hypertens. 17 1999 1879 1884
54. 2 receptor-mediated vasodilation in the heart: effect of myocardial infarction Am. J. Physiol. 281 2001 H2590 H2596
55. M.P. Schuijt, R. de Vries, P.R. Saxena, and A.H.J. Danser Prostanoids, but not nitric oxide, counterregulate angiotensin II mediated vasoconstriction in vivo Eur. J. Pharmacol. 428 2001 331 336
56. M.P. Schuijt, B. Tom, R. de Vries, P.R. Saxena, W. Sluiter, J.P. van Kats, and A.H.J. Danser Superoxide does not mediate the acute vasoconstrictor effects of angiotensin: II. A study in human and porcine arteries J. Hypertens. 21 2003 2335 2344
57. M.M. Silva-Antonialli, R.C. Tostes, L. Fernandes, D.R. Fior-Chadi, E.H. Akamine, M.H. Carvalho, Z.B. Fortes, and D. Nigro A lower ratio of AT(1)/AT(2) receptors of angiotensin II is found in female than in male spontaneously hypertensive rats Cardiovasc. Res. 62 2004 587 593
58. H.M. Siragy, and R.M. Carey The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats J. Clin. Invest. 97 1996 1978 1982
59. H.M. Siragy, and R.M. Carey The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats J. Clin. Invest. 100 1997 264 269
60. H.M. Siragy, T. Senbonmatsu, T. Ichiki, T. Inagami, and R.M. Carey Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor J. Clin. Invest. 104 1999 181 188
61. M. Sollini, M. Frieden, and J.L. Beny Charybdotoxin-sensitive small conductance K(Ca) channel activated by bradykinin and substance P in endothelial cells Br. J. Pharmacol. 136 2002 1201 1209
62. H. Tada, K. Egashira, M. Yamamoto, H. Ueno, M. Takemoto, H. Shimokawa, and A. Takeshita Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists J. Cardiovasc. Pharmacol. 30 1997 313 319
63. B. Tom, R. de Vries, P.R. Saxena, and A.H.J. Danser Bradykinin potentiation by angiotensin-(1-7) and angiotensin-converting enzyme (ACE) inhibitors correlates with ACE C- and N-domain blockade Hypertension 38 2001 95 99
64. B. Tom, A. Dendorfer, R. de Vries, P.R. Saxena, and A.H.J. Danser Bradykinin potentiation by ACE inhibitors: a matter of metabolism Br. J. Pharmacol. 137 2002 276 284
65. B. Tom, I.M. Garrelds, E. Scalbert, A.P. Stegmann, F. Boomsma, P.R. Saxena, and A.H.J. Danser ACE- versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency? Arterioscler. Thromb. Vasc. Biol. 23 2003 251 256
66. R.M. Touyz, D. Endemann, G. He, J.S. Li, and E.L. Schiffrin Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR Hypertension 33 1999 366 372
67. Y. Tsutsumi, H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, Y. Shibasaki, H. Kamihata, M. Inada, and T. Iwasaka Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression Circ. Res. 83 1998 1035 4106
68. Y. Tsutsumi, H. Matsubara, H. Masaki, H. Kurihara, S. Murasawa, S. Takai, M. Miyazaki, Y. Nozawa, R. Ozono, K. Nakagawa, T. Miwa, N. Kawada, Y. Mori, Y. Shibasaki, Y. Tanaka, S. Fujiyama, Y. Koyama, A. Fujiyama, H. Takahashi, and T. Iwasaka Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation J. Clin. Invest. 104 1999 925 935
69. J.P. van Kats, D.J. Duncker, D.B. Haitsma, M.P. Schuijt, R. Niebuur, R. Stubenitsky, F. Boomsma, M.A.D.H. Schalekamp, P.D. Verdouw, and A.H.J. Danser Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II Circulation 102 2000 1556 1563
70. C.A.M. van Kesteren, H.A.A. van Heugten, J.M.J. Lamers, P.R. Saxena, M.A.D.H. Schalekamp, and A.H.J. Danser Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts J. Mol. Cell. Cardiol. 29 1997 2147 2157
71. 2 receptors in the normal and failing human heart J. Pharmacol. Exp. Ther. 284 1998 323 336
72. R.E. Widdop, S.M. Gardiner, P.A. Kemp, and T. Bennett Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174 Br. J. Pharmacol. 107 1992 873 880
73. R.E. Widdop, S.M. Gardiner, P.A. Kemp, and T. Bennett Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II Am. J. Physiol. 264 1993 H117 H125
74. R.E. Widdop, K. Matrougui, B.I. Levy, and D. Henrion AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade Hypertension 40 2002 516 520
75. R.E. Widdop, E.S. Jones, R.E. Hannan, and T.A. Gaspari Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol. 140 2003 809 824
76. J. Xu, O.A. Carretero, Y.H. Liu, E.G. Shesely, F. Yang, A. Kapke, and X.P. Yang Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice Hypertension 40 2002 244 250
77. H. Yamada, M. Akishita, M. Ito, K. Tamura, L. Daviet, J.Y. Lehtonen, V.J. Dzau, and M. Horiuchi AT2 receptor and vascular smooth muscle cell differentiation in vascular development Hypertension 33 1999 1414 1419
78. Z. Yang, C.M. Bove, B.A. French, F.H. Epstein, S.S. Berr, J.M. DiMaria, J.J. Gibson, R.M. Carey, and C.M. Kramer Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction Circulation 106 2002 106 111
79. J. Zhang, and R.E. Pratt The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus J. Biol. Chem. 271 1996 15026 15033
80. C. Zhang, T.W. Hein, W. Wang, and L. Kuo Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function Circ. Res. 92 2003 322 329
81. Y.C. Zhu, Y.Z. Zhu, N. Lu, M.J. Wang, Y.X. Wang, and T. Yao Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling Clin. Exp. Pharmacol. Physiol. 30 2003 911 918